science
plus
.abes.fr
|
explorer
À propos de :
Borea Pier Andrea
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Borea Pier Andrea
Andrea Borea Pier
familyName
Borea
Andrea Borea
Given name
Pier
P. A.
Pier Andrea
is
relates
of
http://hub.abes.fr/acs/periodical/jmcmar/1995/volume_38/issue_9/101021jm00009a007/authorship/5
http://hub.abes.fr/acs/periodical/jmcmar/2007/volume_50/issue_2/101021jm061170a/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/1987/volume_30/issue_9/101021jm00392a002/authorship/4
http://hub.abes.fr/acs/periodical/jmcmar/2003/volume_46/issue_20/101021jm030852k/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/2003/volume_46/issue_7/101021jm021023m/authorship/11
http://hub.abes.fr/acs/periodical/jmcmar/2002/volume_45/issue_17/101021jm020974x/authorship/11
http://hub.abes.fr/acs/periodical/jmcmar/2004/volume_47/issue_22/101021jm0408161/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_1/101021jm049662f/authorship/9
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_6/101021jm040842z/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/2000/volume_43/issue_25/101021jm001047y/authorship/11
http://hub.abes.fr/acs/periodical/jmcmar/2002/volume_45/issue_1/101021jm010924c/authorship/8
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_9/101021jm0490235/authorship/14
http://hub.abes.fr/acs/periodical/chreay/2008/volume_108/issue_1/101021cr0682195/authorship/4
http://hub.abes.fr/acs/periodical/jmcmar/2007/volume_50/issue_26/101021jm070852a/authorship/9
http://hub.abes.fr/acs/periodical/bcches/2003/volume_14/issue_6/101021bc034124n/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_14/101021jm058008c/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/2001/volume_44/issue_23/101021jm010221v/authorship/11
http://hub.abes.fr/acs/periodical/jmcmar/2001/volume_44/issue_17/101021jm010818a/authorship/8
http://hub.abes.fr/acs/periodical/jmcmar/2004/volume_47/issue_6/101021jm0309654/authorship/12
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_15/101021jm050125k/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/2000/volume_43/issue_11/101021jm991140q/authorship/6
http://hub.abes.fr/acs/periodical/jmcmar/2006/volume_49/issue_5/101021jm051147/authorship/9
http://hub.abes.fr/acs/periodical/jmcmar/2003/volume_46/issue_5/101021jm0210212/authorship/12
http://hub.abes.fr/acs/periodical/jmcmar/2006/volume_49/issue_14/101021jm051112/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/2008/volume_51/issue_18/101021jm800586p/authorship/12
http://hub.abes.fr/acs/periodical/jmcmar/2000/volume_43/issue_15/101021jm990075h/authorship/11
http://hub.abes.fr/acs/periodical/jmcmar/2002/volume_45/issue_4/101021jm0109614/authorship/10
http://hub.abes.fr/acs/periodical/jmcmar/2007/volume_50/issue_15/101021jm070443e/authorship/12
http://hub.abes.fr/acs/periodical/jmcmar/2001/volume_44/issue_23/101021jm010901y/authorship/4
http://hub.abes.fr/acs/periodical/jmcmar/1987/volume_30/issue_2/101021jm00385a027/authorship/6
http://hub.abes.fr/acs/periodical/jmcmar/1986/volume_29/issue_4/101021jm00154a021/authorship/6
http://hub.abes.fr/acs/periodical/jmcmar/1995/volume_38/issue_23/101021jm00023a013/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/1985/volume_28/issue_5/101021jm50001a025/authorship/6
http://hub.abes.fr/acs/periodical/jpchax/1994/volume_98/issue_5/101021j100056a024/authorship/4
http://hub.abes.fr/springer/periodical/210/1993/volume_348/issue_1/B962FC631291585BE053120B220A4B9B/authorship/4
http://hub.abes.fr/acs/periodical/jmcmar/1991/volume_34/issue_5/101021jm00109a019/authorship/4
http://hub.abes.fr/springer/periodical/210/1992/volume_346/issue_6/B9638BD8F2EF5C03E053120B220A54D8/authorship/4
is
Author
of
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogs
The influence of physicochemical parameters on the biliary excretion of a series of nitroimidazoles
Synthesis and structure-activity relationships of deltorphins analogs
Enthalpy-entropy compensation in drug-receptor binding
A Concerted Study Using Binding Measurements, X-ray Structural Data, and Molecular Modeling on the Stereochemical Features Responsible for the Affinity of 6-Arylpyrrolo[2,1-d][1,5]benzothiazepines toward Mitochondrial Benzodiazepine Receptors
Synthesis and Interaction of 5-(Substituted-phenyl)-3-methy1-6,7-dihydropyrazolo[4,3-e][1,4]diazepin-8(7H)-ones with Benzodiazepine Receptors in Rat Cerebral Cortex
2-Aralkynyl and 2-Heteroalkynyl Derivatives of Adenosine-5'-N-Ethyluronamide as Selective A2a Adenosine Receptor Agonists
Design, Synthesis, and Biological Evaluation of C9- and C2-SubstitutedPyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as New A2A and A3 AdenosineReceptors Antagonists
Combined Target-Based and Ligand-Based Drug Design Approach as a Tool ToDefine a Novel 3D-Pharmacophore Model of Human A3 Adenosine ReceptorAntagonists: Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine Derivatives as a KeyStudy
Synthesis, Molecular Modeling, and Opioid Receptor Affinity of9,10-Diazatricyclo[4.2.1.12,5]decanes and 2,7-Diazatricyclo[4.4.0.03,8]decanesStructurally Related to 3,8-Diazabicyclo[3.2.1]octanes
Synthesis and Biological Evaluation of NovelN6-[4-(Substituted)sulfonamidophenylcarbamoyl]adenosine-5‘-uronamides as A3Adenosine Receptor Agonists
Asymmetrical Nitrido Tc-99m Heterocomplexes as Potential ImagingAgents for Benzodiazepine Receptors
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine Derivatives as Highly Potent andSelective Human A3 Adenosine Receptor Antagonists: Influence of the Chain atthe N8 Pyrazole Nitrogen
Structure−Affinity Relationships of a Unique Nicotinic Ligand: N-Dimethyl-N4-phenylpiperazinium Iodide (DMPP)
Synthesis, Biological Properties, andMolecular Modeling Investigation of theFirst Potent, Selective, andWater-Soluble Human A3 AdenosineReceptor Antagonist
Adenosine Receptor Antagonists: Translating Medicinal Chemistry andPharmacology into Clinical Utility
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives as AdenosineReceptor Antagonists. Influence of the N5 Substituent on the Affinity at theHuman A3 and A2B Adenosine Receptor Subtypes: A Molecular ModelingInvestigation
Scouting Human A3 Adenosine Receptor Antagonist Binding Mode Using a Molecular Simplification Approach: From Triazoloquinoxaline to a Pyrimidine Skeleton as a Key Study
New Pyrrolo[2,1-f]purine-2,4-dione and Imidazo[2,1-f]purine-2,4-dioneDerivatives as Potent and Selective Human A3 Adenosine Receptor Antagonists
Synthesis and Biological Effects of Novel 2-Amino-3-naphthoylthiophenes asAllosteric Enhancers of the A1 Adenosine Receptor
Effects of adenosine derivatives on human and rabbit platelet aggregation
7-Substituted 5-Amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidinesas A2A Adenosine Receptor Antagonists: A Study on the Importance ofModifications at the Side Chain on the Activity and Solubility
From Tyrosine to Glycine: Synthesis and Biological Activity of Potent Antagonists of thePurinergic P2X7 Receptor
New 2-Arylpyrazolo[4,3-c]quinoline Derivatives as Potent and Selective HumanA3 Adenosine Receptor Antagonists
Pharmacophore Based Receptor Modeling: The Case of Adenosine A3 Receptor Antagonists.An Approach to the Optimization of Protein Models
Synthesis and Biological Evaluation of Novel 1-Deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]-9H-purin-9-yl]-N-ethyl-β-d-ribofuranuronamide Derivatives as Useful Templates for theDevelopment of A2B Adenosine Receptor Agonists
Synthesis and Pharmacology of 6-Substituted Benztropines: Discovery of NovelDopamine Uptake Inhibitors Possessing Low Binding Affinity to the DopamineTransporter
Synthesis, Biological Activity, and Molecular Modeling Investigation of NewPyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine Derivatives as Human A3Adenosine Receptor Antagonists
Further Studies on Nociceptin-Related Peptides: Discovery of a New ChemicalTemplate with Antagonist Activity on the Nociceptin Receptor
Fluorosulfonyl- and Bis-(β-chloroethyl)amino-phenylamino FunctionalizedPyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine Derivatives: IrreversibleAntagonists at the Human A3 Adenosine Receptor and Molecular ModelingStudies
Structure−Activity Studies of the Phe4 Residue of Nociceptin(1−13)-NH2: Identification of Highly Potent Agonists of the Nociceptin/Orphanin FQReceptor
Design, Synthesis, and Biological Evaluation of New 8-Heterocyclic XanthineDerivatives as Highly Potent and Selective Human A2B Adenosine ReceptorAntagonists
Binding Thermodynamics as a Tool To Investigate the Mechanisms ofDrug−Receptor Interactions: Thermodynamics of Cytoplasmic Steroid/NuclearReceptors in Comparison with Membrane Receptors
Synthesis and Biological Studies of a New Series of5-Heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as Human A3Adenosine Receptor Antagonists. Influence of the Heteroaryl Substituent on Binding Affinityand Molecular Modeling Investigations
Synthesis and Biological Evaluation of 2-Amino-3-(4-Chlorobenzoyl)-4-[N-(Substituted) Piperazin-1-yl]Thiophenes as Potent Allosteric Enhancers of the A1 Adenosine Receptor
Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues
Relationship between lipophilic character and urinary excretion of nitroimidazoles and nitrothiazoles in rats
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
